Clinical Trial Update: Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain [Phase 2]

View source ↗

Summary

A Phase 2 open-label trial of thalidomide for chronic prostatitis and chronic pelvic pain has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Pain
• Prostatitis

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Kenneth Peters, MD | Conditions: Chronic Prostatitis, Pelvic Pain | Phase 2 | Status: TERMINATED